SCHEMBL4906071

SCHEMBL4906071

CCc1ccc(S(=O)(=O)N(CC)c2ccc(OCc3cc(F)cc(F)c3)cc2)cc1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP14 P50281 1/20 0.44
ADAM17 P78536 1/20 0.44
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 2/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
KDM4E B2RXH2 1/20 0.42
KEAP1 Q14145 3/20 0.42
NFE2L2 Q16236 3/20 0.42
KMT2A Q03164 4/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 2/20 0.42
ESR1 P03372 2/20 0.42
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAOB P27338 1/20 0.41
MEN1 O00255 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907113 0.92 LMNA (0.53) LMNAMMP2MMP9HSD17B10ALDH1A1
SCHEMBL4906576 0.90 MMP2 (0.45) LMNAMMP2MMP9MMP14ADAM17
SCHEMBL4904188 0.90 LMNA (0.53) LMNAMMP2MMP9MMP14ADAM17
SCHEMBL4906250 0.89 LMNA (0.57) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4900961 0.86 MMP2 (0.49) LMNAMMP2MMP9KEAP1NFE2L2
SCHEMBL4906732 0.85 LMNA (0.47) LMNAMMP2MMP9MMP14ADAM17
SCHEMBL4898076 0.85 LMNA (0.58) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4904151 0.84 LMNA (0.56) LMNAHSD17B10ALDH1A1HPGDALOX15
SCHEMBL4906221 0.83 MMP9 (0.47) LMNAMMP2MMP9MMP14ADAM17
SCHEMBL4895785 0.83 KEAP1 (0.49) LMNAMMP2MMP9MMP14ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885MMP2 4105/4885MMP9 4632/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885MMP2 4105/4885MMP9 4632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.